{"schema_version":"secwatch.filing_event.v1","accession":"0000021076-26-000008","form_type":"8-K","ticker":"CLX","cik":"0000021076","company_name":"CLOROX CO /DE/","filed_at":"2026-02-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.275947+00:00","generated_at":"2026-05-16T05:26:59.226981+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Clorox Q2 FY2026 sales down 1% to $1.67B, EPS $1.29, reaffirms outlook","bullets":["Net sales $1.67B (-1% YoY); organic sales -1%; gross margin 43.2% (-60 bps).","Diluted EPS $1.29 (-16% YoY); adjusted EPS $1.39 (-10% YoY).","YTD operating cash flow $404M (+1%); free cash flow $326M (10.5% of sales).","Segment: Health & Wellness +2%, Household -6%, Lifestyle -5%, International +7%.","CEO Linda Rendle reaffirms FY2026 outlook; cites recently announced GOJO acquisition."],"urls":{"canonical":"https://secwatch.observer/filing/0000021076-26-000008","json":"https://secwatch.observer/filing/0000021076-26-000008.json","markdown":"https://secwatch.observer/filing/0000021076-26-000008.md","text":"https://secwatch.observer/filing/0000021076-26-000008.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/21076/000002107626000008/0000021076-26-000008-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/21076/000002107626000008/clx-20260203.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T05:26:59.226981+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}